Opicapone as First-Line Strategy for the Treatment of Wearing-off in Korean Patients with Parkinson's Disease

This study aimed to explore the efficacy of OPC 50 mg versus an extra 100 mg L-dopa dose to treat early wearing-off in Korean patients with PD.

Source: Parkinsonism and Related Disorders - May 1, 2024 Category: Neurology Authors: J.Y. Lee, J.J. Ferreira, H.I. Ma, J.F. Rocha, B. Jeon, on behalf of Korean OGT_001 study investigators Source Type: research